JCI-accredited hospitals · 45+ hospitals & clinics · Patients from 90+ countries · 24/7 multilingual coordination
Article

What is Ovarian Cancer affect the body? Symptoms & Effects

16 min read
Published by Acibadem Health Point Last updated June 2, 2025

What is Ovarian Cancer affect the body? Symptoms & Effects

What is Ovarian Cancer affect the body? Symptoms & Effects Ovarian cancer occurs when cells in the ovaries or fallopian tubes grow uncontrollably. These organs play a vital role in the reproductive system, producing eggs and hormones essential for fertility and overall health.

In Illinois alone, 847 new cases were reported in 2021, with 470 resulting in fatalities. Most cases, around 85-90%, are epithelial ovarian cancers, originating from the cells covering the ovaries.

Early detection remains challenging due to non-specific symptoms like bloating, pelvic pain, and urinary changes. These signs often mimic common conditions, delaying diagnosis.

When left untreated, the disease can spread to the abdomen and distant organs, complicating treatment. Understanding how cellular mutations lead to cancer is crucial for improving outcomes.

Survival rates vary significantly based on detection timing. Early diagnosis dramatically increases the chances of successful treatment, highlighting the importance of awareness and regular check-ups.

Understanding Ovarian Cancer

Mutations in DNA can trigger abnormal cell development in reproductive organs. These changes often begin in the outer lining of the ovaries, known as the epithelium. Over time, these cells grow uncontrollably, forming tumors that can spread to other areas.

Types of Tumors

There are three main types of tumors: epithelial, germ cell, and stromal. Epithelial ovarian tumors are the most common, starting in the ovary’s outer layer. Germ cell tumors originate from egg-producing cells, while stromal tumors develop in hormone-producing tissues.

How Tumors Form

DNA mutations cause normal cells to become cancer cells. These mutations can be inherited, such as those in the BRCA1 or BRCA2 genes, or acquired over time. Hormonal factors and repeated ovulation cycles may also contribute to cellular damage and repair, increasing the risk of tumor formation.

Once tumors develop, they can spread through the peritoneal fluid, a process known as metastasis. This fluid circulates in the abdominal cavity, allowing cancer cells to reach other organs. Understanding these processes helps researchers develop better treatments.

What is Ovarian Cancer Affect the Body?

Uncontrolled growth in reproductive tissues can lead to severe health complications. This condition often disrupts the reproductive system, impacting hormone production and menstrual cycles. Additionally, it can spread to other areas, causing widespread effects.

Reproductive System Disruption

When abnormal cells develop in the ovaries or fallopian tubes, they can interfere with normal functions. Hormonal imbalances may occur, leading to irregular periods or fertility issues. Tumor growth can also compress nearby organs, such as the bladder or rectum, causing discomfort.

Spread to Other Organs

In advanced stages, abnormal cells often move through the peritoneal cavity. This process, known as cancer spread, commonly affects the intestines, liver, and stomach. Stage IV cases may involve the lungs or spleen, complicating treatment and reducing quality of life. What is Ovarian Cancer affect the body? Symptoms & Effects

What is Ovarian Cancer affect the body? Symptoms & Effects Other complications include ascites, where fluid builds up in the abdomen, causing distension. Bowel obstructions and liver capsule involvement are also risks. Lymphatic and hematogenous spread can further impact distant organs, leading to additional symptoms.

Organ Impact
Intestines Bowel obstruction, discomfort
Liver Pain, capsule involvement
Stomach Compression, digestive issues
Lungs Breathing difficulties
Spleen Enlargement, pain

Common Symptoms of Ovarian Cancer

Recognizing the signs of this condition early can improve outcomes significantly. Symptoms often appear subtle, making them easy to overlook. However, persistent changes in the body should never be ignored.

Early Warning Signs

Early-stage symptoms can mimic common issues like digestive discomfort. Persistent bloating lasting more than three weeks is a key indicator. Pelvic pressure and urinary urgency are also common.

Post-menopausal bleeding should raise suspicion, as it may signal underlying issues. Fatigue and unexplained weight loss are non-specific but often reported. Keeping a symptom diary can help track patterns and aid diagnosis.

Advanced Symptoms

In later stages, symptoms become more pronounced. Abdominal distension may occur due to fluid buildup, known as ascites. Tumor masses can also cause visible swelling.

What is Ovarian Cancer affect the body? Symptoms & Effects Bowel habit changes, such as constipation or diarrhea, are linked to peritoneal involvement. Respiratory symptoms like pleural effusion may develop, leading to breathing difficulties. Anorexia and cachexia are common in advanced cases.

Symptom Description
Persistent Bloating Lasts over three weeks, often with discomfort
Pelvic Pressure Feeling of heaviness or fullness in the pelvic area
Urinary Urgency Frequent need to urinate, even with minimal output
Abdominal Distension Swelling due to ascites or tumor mass
Pleural Effusion Fluid buildup in the lungs, causing breathing issues

How is Ovarian Cancer Diagnosed?

Accurate diagnosis is critical for effective treatment of reproductive health conditions. Medical professionals use a combination of imaging, blood tests, and surgical evaluation to confirm abnormalities. Early detection relies on these methods to identify issues before they progress.

Imaging Tests

Transvaginal ultrasound is often the first-line imaging tool. It helps visualize the ovaries and detect potential tumors. For more detailed characterization, CT or MRI scans may be used. These advanced tests provide clearer images of tumor size and spread.

Blood Tests and CA-125

The CA-125 blood test measures a protein often elevated in certain conditions. However, its sensitivity and specificity have limitations, especially in premenopausal women. False positives can occur due to other health issues, making it less reliable as a standalone diagnosis tool.

Surgical Evaluation

Laparoscopic biopsy remains the gold standard for confirmation. During this surgery, tissue samples are collected and analyzed. Frozen section analysis provides immediate results, while the Risk of Malignancy Index (RMI) scoring system helps assess tumor likelihood. NCCN guidelines outline the diagnostic workup process to ensure accuracy.

Stages of Ovarian Cancer

The FIGO staging system provides a detailed framework for classification. It helps medical professionals assess the extent of abnormal cell growth and spread. Understanding these stages is crucial for determining the most effective treatment approach.

Stage I to Stage IV

Stage I involves limited growth within the ovaries, with substages IA to IC based on tumor size and rupture. Stage II indicates spread to pelvic organs, while Stage III includes abdomen involvement, such as implants larger than 2cm. Stage IV signifies distant metastasis, often affecting the lungs or spleen.

Lymph node involvement upstages the condition, emphasizing the importance of thorough evaluation. Peritoneal cytology plays a role in staging, as microscopic spread can influence prognosis. Optimal cytoreduction during surgery aims to remove visible tumors, improving outcomes.

How Staging Affects Treatment

Early-stage cases often require less aggressive treatment, focusing on surgery and localized therapies. Advanced stages may involve neoadjuvant chemotherapy to shrink tumors before surgery. Restaging after recurrence helps adjust plans based on disease progression. What is Ovarian Cancer affect the body? Symptoms & Effects

Five-year survival rates vary significantly by stage, highlighting the importance of early detection. Stage migration concepts ensure accurate classification over time. Understanding these factors empowers patients and providers to make informed decisions.

Treatment Options for Ovarian Cancer

Effective management of reproductive health conditions often involves a combination of surgical and medical approaches. Tailored plans are designed to address specific needs, ensuring the best possible outcomes. Below, we explore the primary methods used in modern care.

Surgery

Debulking surgery is a common procedure aimed at removing as much abnormal tissue as possible. The goal is to leave less than 1cm of residual tissue. Two main approaches include primary debulking surgery (PDS) and neoadjuvant chemotherapy followed by interval debulking surgery (NACT-IDS).

For younger patients, fertility-sparing surgery may be an option, preserving reproductive function. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is under investigation for advanced cases. These methods aim to improve survival rates and quality of life.

Chemotherapy

Chemotherapy remains a cornerstone of treatment, often using carboplatin and paclitaxel as first-line agents. Platinum sensitivity plays a key role in determining response. Patients with platinum-resistant cases may require alternative therapies.

Administration methods include intravenous (IV) and intraperitoneal (IP) delivery. PARP inhibitor maintenance therapy has shown promise in extending remission periods. Managing side effects, such as nausea and fatigue, is crucial for patient comfort.

Radiation Therapy

While less commonly used, radiation therapy can play a palliative role in managing metastasis. It helps alleviate symptoms like pain and discomfort in advanced stages. Biomarker testing is increasingly used to identify targeted therapies, offering more personalized care.

  • PDS vs NACT-IDS: Choosing the right surgical approach depends on disease extent and patient health.
  • Platinum Sensitivity: Determines the effectiveness of chemotherapy agents.
  • PARP Inhibitors: Extend remission by targeting specific cellular pathways.
  • CRS/HIPEC: A promising combination for advanced cases.
  • Side Effect Management: Focuses on improving quality of life during treatment.

Risk Factors for Ovarian Cancer

Understanding the factors that increase susceptibility to certain conditions can help in early prevention and management. Both genetic and lifestyle elements play a role in influencing risk. Identifying these factors allows for better awareness and proactive health measures.

Genetic Factors

Family history significantly impacts susceptibility. Individuals with first-degree relatives diagnosed with certain conditions face a higher risk. For example, 5-10% of cases are linked to BRCA1 or BRCA2 mutations.

Lynch syndrome, a hereditary condition, also increases vulnerability. Genetic testing can identify these mutations, providing valuable insights for prevention. Breast-ovarian cancer syndrome is another genetic link, emphasizing the importance of family health records.

Lifestyle and Environmental Factors

Reproductive history plays a role. Nulliparity (never having given birth) and late menopause are associated with higher risk. Conversely, oral contraceptives offer protective effects, reducing susceptibility by up to 50%.

Obesity and metabolic syndrome are additional contributors. Excess body weight can disrupt hormonal balance, increasing vulnerability. Environmental exposures, such as asbestos or talcum powder, remain controversial but are under scrutiny.

Endometriosis triples the likelihood of developing certain conditions. Galactose metabolism hypotheses suggest dietary factors may also play a role. Postmenopausal hormone therapy has been linked to elevated risk, highlighting the need for careful consideration in treatment plans.

Can Ovarian Cancer Be Prevented?

Proactive measures can significantly reduce susceptibility to certain reproductive health conditions. While complete prevention may not always be possible, understanding risk factors and taking steps to control them can make a difference. Both lifestyle adjustments and medical interventions play a role in lowering vulnerability.

Lifestyle Changes

Dietary modifications can help reduce susceptibility. A low-fat diet rich in cruciferous vegetables like broccoli and cauliflower has shown protective effects. Regular physical activity and maintaining a healthy weight are also beneficial.

Breastfeeding for extended periods can lower susceptibility due to hormonal changes. Additionally, avoiding tobacco and limiting alcohol intake contribute to overall health and reduced vulnerability.

Medical Interventions

For those with a strong family history, risk-reducing surgery may be an option. Bilateral salpingo-oophorectomy, the removal of both ovaries and fallopian tubes, can reduce susceptibility by up to 80%. Opportunistic salpingectomy during other procedures is also gaining popularity.

Oral contraceptives offer protective benefits, decreasing susceptibility by 50% with five years of use. Genetic counseling is recommended for individuals with known mutations, such as BRCA1 or BRCA2, to explore preventive options.

Research on aspirin and NSAIDs suggests potential protective effects, though findings are still inconclusive. Hormone replacement therapy (HRT) should be carefully considered, as it may increase susceptibility in some cases.

Living with Ovarian Cancer

Living with this condition requires adapting to physical and emotional challenges. Managing symptoms and seeking support are essential for improving quality of life. Below, we explore strategies to navigate these challenges effectively.

Managing Symptoms

Fatigue is a common issue, but simple strategies can help. Prioritizing rest, maintaining a balanced diet, and gentle exercise can boost energy levels. For severe cases, doctors may recommend specific treatment plans.

Ascites, or fluid buildup in the abdomen, often requires drainage procedures. This can relieve discomfort and improve breathing. Neuropathy, a side effect of chemotherapy, may be managed with medications or physical therapy.

Bowel obstructions are a serious complication. Palliative care focuses on relieving pain and improving comfort. Support from healthcare providers is crucial during this time.

Emotional and Psychological Support

Body image concerns, especially after hysterectomy, are common. Counseling and support groups can help individuals cope. Organizations like the American Cancer Society (ACS) and National Cancer Institute (NCI) offer valuable resources.

Cognitive behavioral therapy can address anxiety and depression. Survivorship care plans provide guidance for life after treatment. Advance care planning ensures patients’ wishes are respected.

Living with this condition is a journey, but no one has to face it alone. With the right strategies and support, patients can find balance and hope.

Ovarian Cancer and Family History

Understanding your family’s health background can reveal critical insights into potential risks. A strong family history of certain conditions may increase susceptibility. Genetic factors, such as mutations in the BRCA genes, play a significant role in determining risk levels. What is Ovarian Cancer affect the body? Symptoms & Effects

Genetic Testing

Genetic testing is a powerful tool for identifying inherited mutations. The NCCN recommends testing for individuals with two or more affected relatives or Ashkenazi Jewish heritage. Multi-gene panel testing can detect variants beyond BRCA, including those with uncertain significance.

Insurance coverage for testing varies, but many plans now include it for high-risk individuals. Cascade testing, where relatives of a carrier are also tested, helps identify others at risk. Prophylactic surgery reduces susceptibility by up to 80% in carriers.

Family Risk Assessment

Pedigree analysis is a method used to map out family health patterns. It helps identify potential risk factors and guide prevention strategies. For example, a first-degree relative with the condition increases lifetime risk to 3.1%.

Surveillance protocols for carriers include regular screenings and monitoring. Pancreatic cancer screening is recommended for those with BRCA2 mutations. PARP inhibitor studies show promise in chemoprevention for high-risk individuals.

Surveillance Protocol Details
Regular Screenings Includes transvaginal ultrasound and CA-125 tests
Pancreatic Cancer Screening Recommended for BRCA2 carriers
PARP Inhibitors Used in chemoprevention studies
Prophylactic Surgery Reduces risk by up to 80%

Ovarian Cancer in Different Age Groups

Age plays a significant role in how reproductive health conditions develop and progress. These conditions manifest differently in younger and older women, influencing diagnosis, treatment, and outcomes. Understanding these variations helps tailor care to individual needs.

Younger Women

In women under 40, germ cell tumors are more common. These tumors originate from egg-producing cells and often require unique treatment approaches. Fertility preservation is a critical consideration for younger patients, especially those planning future pregnancies.

  • Fertility-Sparing Surgery: This option allows younger women to retain reproductive function while addressing the condition.
  • Delayed Diagnosis: Symptoms in younger women are often mistaken for less serious issues, leading to delayed detection.
  • Chemotherapy Effects: Treatment can induce early menopause, impacting long-term health and fertility.

Post-Menopausal Women

Over 50% of cases occur in women aged 63 and older. Epithelial tumors are the most common in this age group, often requiring aggressive treatment. Post-menopausal women also face unique challenges, such as managing comorbidities and hormone replacement therapy (HRT) considerations.

  • Survival Differences: Older women often have lower survival rates due to advanced diagnoses and existing health conditions.
  • HRT Post-Oophorectomy: The removal of ovaries may necessitate HRT to manage menopausal symptoms.
  • Clinical Trial Disparities: Elderly patients are often underrepresented in research, limiting access to innovative treatments.

Understanding these age-related differences ensures more effective and personalized care. Whether addressing fertility concerns in younger women or managing comorbidities in older patients, tailored approaches improve outcomes and quality of life.

Support and Resources for Patients

Navigating health challenges often requires more than medical treatment—it demands emotional and practical support. Patients and their families can benefit from a wide range of programs and materials designed to ease the journey. These resources provide guidance, comfort, and tools to manage daily life during and after treatment.

Connecting Through Support Groups

Joining a support group can offer a sense of community and understanding. Organizations like the American Cancer Society (ACS) host Hope Lodge programs, providing free lodging for patients traveling for treatment. Online communities and local meetups also allow individuals to share experiences and coping strategies.

Empowering Through Educational Materials

Access to reliable education is crucial for informed decision-making. The National Cancer Institute’s (NCI) PDQ database offers up-to-date information on treatments and research. The Foundation for Women’s Cancer provides brochures, webinars, and workshops to help patients understand their condition and options.

Below is a table of additional resources available to patients:

Resource Details
National Helpline 1-800-227-2345 (ACS)
Financial Assistance Grants for treatment costs
Patient Navigation Guidance through treatment steps
Clinical Trial Matching Tools to find relevant studies
Nutrition Counseling Diet plans for recovery
Transportation Aid Ride services for appointments
Survivorship Workshops Programs for life after treatment
Palliative Care Access Support for symptom management

These resources aim to address both the physical and emotional aspects of health challenges. By leveraging these tools, patients can focus on healing and improving their quality of life.

Advances in Ovarian Cancer Research

Recent breakthroughs in medical research are transforming how we approach reproductive health conditions. Innovations in clinical trials and treatment methods are offering new hope for patients. These advancements focus on improving outcomes and enhancing quality of life.

Clinical Trials

Adaptive trial designs are revolutionizing the way studies are conducted. These methods allow researchers to modify protocols based on real-time data, improving efficiency. Tumor microenvironment targets are also gaining attention, as they play a critical role in disease progression.

Liquid biopsy detection methods are another promising area. These non-invasive tests analyze circulating tumor DNA (ctDNA) to monitor disease status. This approach provides valuable insights without the need for invasive procedures.

New Treatment Developments

PARP inhibitors have shown significant success in prolonging remission periods. These drugs target specific pathways in cells, preventing them from repairing DNA damage. Immunotherapy, particularly PD-L1 inhibitors, is currently in phase III trials, offering potential for long-term control.

Antibody-drug conjugates, such as Mirvetuximab, are another exciting development. These therapies combine targeted antibodies with potent drugs, delivering precise treatment to affected areas. Anti-angiogenesis combinations are also being explored to cut off blood supply to tumors.

Advancement Details
PARP Inhibitors Prolong remission by targeting DNA repair pathways
Immunotherapy PD-L1 inhibitors in phase III trials
Liquid Biopsy Non-invasive ctDNA monitoring
Antibody-Drug Conjugates Precise delivery of potent drugs
Anti-Angiogenesis Cutting off blood supply to tumors

These advancements highlight the importance of ongoing research in improving patient outcomes. With continued innovation, the future of reproductive health care looks promising.

Taking the Next Steps

Proactive healthcare engagement is essential for managing health challenges effectively. Recognizing symptoms early and reporting them promptly can lead to timely diagnosis and better outcomes. Always discuss any persistent changes with your healthcare provider.

When meeting with oncologists, ask about treatment options, potential side effects, and long-term care plans. Seeking a second opinion can provide additional clarity and confidence in your care strategy. Biomarker retesting at recurrence ensures the most accurate approach to ongoing management.

Survivorship clinics offer specialized care to address physical and emotional needs post-treatment. Lifestyle modifications, such as a balanced diet and regular exercise, support overall well-being. Annual follow-ups and genetic counseling sessions are critical for monitoring health and managing risks.

Be aware of emergency symptoms, such as severe pain or breathing difficulties, and seek immediate medical attention. Staying informed and engaged in your care empowers you to take control of your health journey.

We’re With You at Every Step

How can we help you today?

Treatments are delivered at our JCI-accredited hospitals — Acıbadem International
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.